Biomarkers for immune checkpoint inhibitors--authors' reply

Lancet Oncol. 2014 Jan;15(1):e1-2. doi: 10.1016/S1470-2045(13)70573-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Drug Resistance, Neoplasm / drug effects*
  • Female
  • Humans
  • Male
  • Mesothelioma / drug therapy*
  • Pleural Neoplasms / drug therapy*
  • Salvage Therapy*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents